Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-14 10:01 am Purchase | 13G | BIORA THERAPEUTICS INC. BIOR | HIGHBRIDGE CAPITAL MANAGEMENT LLC | 19,958,480 9.990% | 19,958,480 (New Position) | View |
| 2024-10-09 5:40 pm Purchase | 13D | BIORA THERAPEUTICS INC. BIOR | Athyrium Opportunities III Co-Invest 1 LP | 25,744,527 49.900% | 307,156 (+1.21%) | View |
| 2024-09-13 10:37 am Unchanged | 13D | BIORA THERAPEUTICS INC. BIOR | Athyrium Opportunities III Co-Invest 1 LP | 25,437,371 49.900% | 0 (Unchanged) | View |
| 2024-08-20 4:15 pm Purchase | 13G | BIORA THERAPEUTICS INC. BIOR | Davidson Kempner Capital Management LP | 37,315,903 9.900% | 37,315,903 (New Position) | View |
| 2024-08-14 9:58 pm Purchase | 13D | BIORA THERAPEUTICS INC. BIOR | Athyrium Opportunities III Co-Invest 1 LP | 25,437,371 49.900% | 582,910 (+2.35%) | View |
| 2024-07-08 9:42 pm Purchase | 13D | BIORA THERAPEUTICS INC. BIOR | Athyrium Opportunities III Co-Invest 1 LP | 24,854,461 49.900% | 24,854,461 (New Position) | View |
| 2024-04-02 8:43 pm Purchase | 13D | BIORA THERAPEUTICS INC. BIOR | Athyrium Opportunities 2020 LP | 19,306,283 49.900% | 3,091,758 (+19.07%) | View |
| 2024-02-14 2:43 pm Purchase | 13G | BIORA THERAPEUTICS INC. BIOR | ARMISTICE CAPITAL LLC | 1,074,895 3.800% | 1,074,895 (New Position) | View |
| 2023-12-20 4:35 pm Purchase | 13D | BIORA THERAPEUTICS INC. BIOR | Athyrium Opportunities 2020 LP | 16,214,525 49.900% | 3,865,687 (+31.30%) | View |
| 2023-09-19 4:15 pm Purchase | 13D | BIORA THERAPEUTICS INC. BIOR | Athyrium Opportunities 2020 LP | 12,348,838 49.900% | 8,679,260 (+236.52%) | View |
| 2023-03-13 4:18 pm Purchase | 13D | BIORA THERAPEUTICS INC. BIOR | Athyrium Opportunities 2020 LP | 3,669,578 32.700% | 824,135 (+28.96%) | View |
| 2023-02-14 12:05 pm Purchase | 13G | BIORA THERAPEUTICS INC. BIOR | ARMISTICE CAPITAL LLC | 12,989,648 5.700% | 12,989,648 (New Position) | View |
| 2023-01-12 4:46 pm Sale | 13D | BIORA THERAPEUTICS INC. BIOR | Athyrium Opportunities 2020 LP | 2,845,443 27.800% | -68,290,626 (-96.00%) | View |
| 2022-11-18 4:30 pm Purchase | 13D | BIORA THERAPEUTICS INC. BIOR | Athyrium Opportunities 2020 LP | 71,136,069 28.400% | 4,008,924 (+5.97%) | View |
| 2022-02-14 3:32 pm Sale | 13G | BIORA THERAPEUTICS INC. BIOR | CVI Investments Inc. | 3,750,000 2.200% | -8,497,229 (-69.38%) | View |
| 2021-11-26 4:45 pm Purchase | 13D | BIORA THERAPEUTICS INC. BIOR | Athyrium Opportunities 2020 LP | 67,127,145 31.100% | 67,127,145 (New Position) | View |
| 2021-08-30 10:15 am Purchase | 13G | BIORA THERAPEUTICS INC. BIOR | CVI Investments Inc. | 12,247,229 9.900% | 12,247,229 (New Position) | View |
| 2021-08-27 4:22 pm Unchanged | 13D | BIORA THERAPEUTICS INC. BIOR | Athyrium Capital Management LP | 73,668,205 47.000% | 0 (Unchanged) | View |
| 2021-06-21 4:32 pm Purchase | 13D | BIORA THERAPEUTICS INC. BIOR | Athyrium Capital Management LP | 73,668,205 64.200% | 17,462,447 (+31.07%) | View |
| 2020-12-11 4:30 pm Purchase | 13D | BIORA THERAPEUTICS INC. BIOR | Athyrium Capital Management LP | 56,205,758 67.100% | 32,902,412 (+141.19%) | View |